Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:FIVE
NasdaqGS:FIVESpecialty Retail

Five Below (FIVE) Is Down 7.0% After Earnings Beat And Upbeat Guidance - Has The Bull Case Changed?

Earlier this month, Five Below reported quarterly revenue of US$1.73 billion, about 1.1% above analyst expectations, alongside stronger‑than‑expected earnings and upbeat guidance that management linked to effective execution of its customer‑focused growth strategy. At the same time, the retailer has been expanding its footprint and seasonal assortment, from new store openings to fresh low‑priced spring and pet products, underscoring how its value formula is being applied across more...
NYSE:ABG
NYSE:ABGSpecialty Retail

A Look At Asbury Automotive Group’s (ABG) Valuation After Its Renovated Support Center Opening

Asbury Automotive Group (ABG) is drawing fresh investor attention after celebrating the grand opening of its renovated Dealership Support Center in Sandy Springs, a project tied to 350 new local jobs. See our latest analysis for Asbury Automotive Group. The grand opening comes as Asbury’s recent share price performance has been mixed, with a 7 day share price return of 4.40% contrasting with a 90 day share price return decline of 16.91% and a 1 year total shareholder return of 9.53% in the...
TSX:POU
TSX:POUOil and Gas

Will Dividend Payout and CPS Debenture Buy Change Paramount Resources' (TSX:POU) Capital Allocation Narrative?

Paramount Resources Ltd. has declared a cash dividend of C$0.05 per common share, paid on April 30, 2026 to shareholders of record on April 15, 2026, and earlier acquired additional secured convertible debentures of Canadian Premium Sand Inc. in a private placement. This combination of returning cash to shareholders while increasing exposure to Canadian Premium Sand through convertible debentures highlights Paramount’s parallel focus on income and sector-focused capital deployment. We’ll now...
NYSE:EVR
NYSE:EVRCapital Markets

Is Evercore’s (EVR) Zacks Upgrade Recasting Its Growth Story Or Just Repricing Expectations?

Evercore recently received a Zacks Rank #2 (Buy) upgrade and was highlighted as a Growth at a Reasonable Price candidate, reflecting improving earnings estimates, supportive analyst opinions, and interest ahead of its April 21, 2026 Q1 earnings report. This combination of stronger earnings expectations, favorable valuation metrics, and broad analyst optimism has reinforced the view that Evercore’s fundamentals and business mix are gaining renewed attention among investors. Next, we’ll...
NYSE:CBL
NYSE:CBLRetail REITs

Will CBL & Associates Properties' (CBL) Higher Dividend Baseline Redefine Its Income Reliability Narrative?

CBL & Associates Properties recently boosted its first-quarter 2026 payout by approving a special US$0.175 per-share cash dividend, lifting the total quarterly dividend to US$0.625 and implying an annualized rate of US$2.50 per common share, subject to ongoing Board approval. This move effectively raises the company’s regular dividend baseline, signaling a stronger commitment to returning cash to shareholders and potentially reshaping how investors view the reliability of its income...
TSXV:FCA.UN
TSXV:FCA.UNResidential REITs

April 2026 TSX Penny Stocks To Watch

As the Canadian market navigates a backdrop of rising inflation and fluctuating oil prices, the S&P/TSX index has shown resilience with a notable recovery from its mid-March lows. In such times, investors might find potential in penny stocks, which often represent smaller or newer companies. Despite being considered an outdated term by some, these stocks continue to offer intriguing opportunities for those looking beyond traditional investment avenues.
NYSE:NTB
NYSE:NTBBanks

Should Strong Q4 Beat, Trust Acquisition and Buybacks Require Action From Bank of Butterfield (NTB) Investors?

Bank of N.T. Butterfield & Son recently reported fourth-quarter results that surpassed analyst expectations for both net income and revenue, highlighting solid performance across its banking and trust operations. At the same time, the bank moved to expand its trust footprint through the planned acquisition of Rawlinson & Hunter Guernsey and reinforced capital returns via a newly approved share repurchase program. Now we’ll examine how these stronger-than-expected earnings and trust-business...
NasdaqGS:ROAD
NasdaqGS:ROADConstruction

Why Construction Partners (ROAD) Is Up 9.2% After U.S.–Iran Ceasefire Eases Fuel Cost Fears

The past week’s U.S.–Iran “double-sided” ceasefire agreement, tied to reopening the Strait of Hormuz, has eased concerns over fuel and logistics costs for infrastructure contractors such as Construction Partners. This shift in geopolitical risk could support a release of deferred road and maintenance work, reinforcing Construction Partners’ existing revenue visibility and backlog strength. With expectations for lower fuel and logistics pressures now in focus, we’ll explore how this...
NYSE:EMN
NYSE:EMNChemicals

A Look At Eastman Chemical (EMN) Valuation As Recent Momentum Contrasts With Longer Term Returns

What recent performance suggests about Eastman Chemical (EMN) With no single headline event driving attention today, Eastman Chemical (EMN) is drawing interest after a recent share price around $74.25 and a mixed return profile across the past year and the past 3 months. See our latest analysis for Eastman Chemical. The recent 1-month share price return of 7.22% and year-to-date share price return of 15.40% contrast with a 1-year total shareholder return decline of 1.85%. This suggests...
NasdaqGS:MGNI
NasdaqGS:MGNIMedia

Is There Now An Opportunity In Magnite (MGNI) After Recent Share Price Swings?

If you are wondering whether Magnite's current share price reflects its true worth, this breakdown will help you separate price from value. With the stock at US$11.98, recent returns have been mixed, including a 1.5% decline over 7 days, a 0.8% gain over 30 days, a 25.4% decline year to date, and a 23.8% gain over 1 year, while the 5 year return sits at a 66.8% decline. These moves sit against a longer track record that includes a 24.4% gain over 3 years, which can shape how investors think...
TSX:ATZ
TSX:ATZSpecialty Retail

A Look At Aritzia (TSX:ATZ) Valuation After AI Max Driven Revenue Growth

AI driven advertising shift puts Aritzia (TSX:ATZ) in focus Aritzia (TSX:ATZ) is drawing fresh attention after reporting a substantial year over year revenue lift linked to Google’s AI Max advertising tool. This development is raising questions about how this operational shift could influence investor views. See our latest analysis for Aritzia. At a share price of CA$127.42, Aritzia has recently seen strong near term momentum, with a 7 day share price return of 11.15% and a 1 month share...
NasdaqGS:KC
NasdaqGS:KCIT

Why Kingsoft Cloud Holdings (KC) Is Up 11.3% After Surging AI-Driven Q4 Earnings And Billing Growth

In early April 2026, Kingsoft Cloud reported a strong fourth quarter, with both revenue and non-GAAP EBITDA exceeding market expectations and management pointing to very large year-over-year growth in AI-related gross billing. The company also emphasized that intelligent computing demand is set to remain a central focus into 2026, underscoring how AI workloads are becoming a core driver of its cloud business mix. Next, we’ll examine how this surge in AI-related activity and...
NasdaqGS:CYTK
NasdaqGS:CYTKBiotechs

Did Insider Sales and Myqorzo Optimism Just Recast Cytokinetics' (CYTK) Investment Narrative?

Earlier this month, Cytokinetics’ Executive Vice President of Research & Development, Fady Malik, exercised stock options and sold 4,500 shares as the company prepared to present at the 25th Annual Needham Virtual Healthcare Conference on April 13, 2026. These insider transactions occurred alongside increasingly positive analyst commentary highlighting the recent Myqorzo approval, extended intellectual property protection, and upcoming ACACIA-HCM Phase 3 trial data as key drivers for...
NasdaqCM:VRDN
NasdaqCM:VRDNBiotechs

A Look At Viridian Therapeutics (VRDN) Valuation After Positive REVEAL-1 Phase 3 Elegrobart Results

Phase 3 REVEAL-1 results put elegrobart in focus Viridian Therapeutics (VRDN) just reported statistically significant, positive topline data from its Phase 3 REVEAL-1 trial of elegrobart in active thyroid eye disease, a material update that reshapes how you might look at the stock. See our latest analysis for Viridian Therapeutics. The REVEAL-1 update lands after a volatile stretch, with the share price at $14.95, a 7 day share price return of 7.55% but a 90 day share price return of 53.27%,...
NasdaqCM:FRHC
NasdaqCM:FRHCCapital Markets

Is Freedom Holding (FRHC) Overvalued After Recent Share Price Momentum And Premium P/S Multiple

What recent returns say about Freedom Holding Freedom Holding (FRHC) has drawn attention after a recent share price move, with the stock showing a 0.2% decline over the past day but double digit gains over the past month. See our latest analysis for Freedom Holding. Putting the recent move in context, Freedom Holding’s 30 day share price return of 14.28% and year to date gain of 21.42%, alongside a 5 year total shareholder return of 205.72%, indicate that momentum has been building over both...
NYSE:SQM
NYSE:SQMChemicals

Three Stocks Estimated To Be Undervalued In April 2026

The United States market has shown robust performance, rising 3.1% over the last week and 27% over the past year, with earnings projected to grow by 16% annually. In such a thriving environment, identifying stocks that are potentially undervalued can offer opportunities for investors seeking to capitalize on discrepancies between current stock prices and their intrinsic values.
NasdaqGS:EQPT
NasdaqGS:EQPTTrade Distributors

April 2026's Leading Growth Stocks With Strong Insider Ownership

Over the last 7 days, the United States market has risen by 3.1%, contributing to a robust 27% increase over the past year, with earnings projected to grow by 16% annually in the coming years. In this thriving environment, identifying growth companies with strong insider ownership can be key as it often signals confidence in their long-term potential and alignment of interests between management and shareholders.
NasdaqCM:SNDL
NasdaqCM:SNDLPharmaceuticals

Akebia Therapeutics Leads The Pack Of 3 Promising Penny Stocks

The United States market has shown robust performance, climbing 3.1% over the last week and 27% over the past year, with earnings projected to grow by 16% annually. In this context of market growth, identifying stocks with strong financials can be crucial for investors seeking potential opportunities. Penny stocks, though often seen as a term from earlier market days, still represent a segment where smaller or newer companies might offer both affordability and significant growth potential.
NYSE:EPAC
NYSE:EPACMachinery

Discovering US Undiscovered Gems for April 2026

The United States market has shown robust performance, rising 3.1% over the last week and climbing 27% in the past year, with anticipated annual earnings growth of 16% in the years ahead. In this thriving environment, identifying stocks that offer unique value propositions and strong potential for growth can be key to uncovering hidden opportunities.
NasdaqCM:VABK
NasdaqCM:VABKBanks

Top Dividend Stocks To Consider In April 2026

The United States market has experienced a robust performance, rising 3.1% in the last week and an impressive 27% over the past year, with earnings projected to grow by 16% annually in the coming years. In this thriving environment, identifying dividend stocks that offer reliable income and potential for growth can be a strategic move for investors seeking stability and returns amidst dynamic market conditions.
NYSE:GAM
NYSE:GAMCapital Markets

General American Investors Company (GAM) Valuation Check After Recent Share Price Strength

General American Investors Company: recent performance in focus General American Investors Company (GAM) has attracted fresh attention after recent price moves, with returns of 0.6% over the past day and about 4.1% over the past week shaping investor interest. See our latest analysis for General American Investors Company. At a latest share price of $61.71, the stock’s recent 7 day share price return of 4.1% sits alongside a 1 year total shareholder return of 37.8%. This suggests momentum has...
NYSE:SBR
NYSE:SBROil and Gas

A Look At Sabine Royalty Trust’s Valuation As April Output Eases And Distribution Is Declared

Production update and monthly distribution set the tone Sabine Royalty Trust (SBR) reported April 2026 production with slightly lower oil and gas volumes than the previous month, while also declaring a monthly cash distribution of $0.324970 per unit to unit holders. See our latest analysis for Sabine Royalty Trust. At a share price of $75.78, Sabine Royalty Trust has paired its latest production and distribution update with building momentum, with a 90 day share price return of 10.0% and a 1...